感染性創傷ケア管理市場 - 世界の産業規模、シェア、動向、機会、予測：製品タイプ別、創傷タイプ別、地域別、競合、2020年～2030年

感染性創傷ケア管理の世界市場規模は、2024年に14億2,000万米ドルとなり、2030年までCAGR 7.13％で成長すると予測されています。

この市場には、怪我や手術、慢性的な健康状態によって生じる感染性の創傷を予防、治療、管理することを目的とした幅広い製品とサービスが含まれます。これらの創傷は、細菌や真菌などの有害な微生物の存在によって特徴付けられ、合併症を予防するために専門的なケアが必要となります。製品には、抗菌ドレッシング材、局所抗生物質、創傷洗浄剤、高度なケアソリューションなどがあります。技術の進歩は、抗菌性能と組織再生を向上させることで、創傷ケア製品の有効性を高め続けています。糖尿病や肥満などの慢性疾患の増加も、効果的な創傷ケアソリューションへの需要を高めています。ヘルスケアシステムは世界的に早期介入と感染対策を重視しているため、感染性創傷ケア管理分野は着実かつ持続的な成長が見込まれます。

市場促進要因

慢性疾患の増加

主な市場課題

抗菌薬耐性

主要市場動向

再生医療

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の感染性創傷ケア管理市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 製品タイプ別（治療薬、デバイス）
  • 創傷タイプ別（糖尿病、低酸素症／組織灌流不良、その他）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024年）
• 製品市場マップ
  • 製品タイプ別
  • 創傷タイプ別
  • 地域別

第6章 北米の感染性創傷ケア管理市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の感染性創傷ケア管理市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の感染性創傷ケア管理市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア

第9章 南米の感染性創傷ケア管理市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの感染性創傷ケア管理市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • アラブ首長国連邦
  • サウジアラビア
  • 南アフリカ

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品開発
• 最近の動向

第13章 ポーター分析

第14章 PESTEL分析

第15章 競合情勢

• Molnlycke Health Care AB
• Hartmann Group
• Smith & Nephew PLC
• 3M Company.
• Smith & Nephew PLC
• Medtronic Plc
• B Braun Melsungen AG
• Johnson & Johnson
• Molnlycke Healthcare AB
• Conva Tec Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Infectious Wound Care Management Market was valued at USD 1.42 billion in 2024 and is projected to grow at a CAGR of 7.13% through 2030. This market encompasses a broad spectrum of products and services aimed at preventing, treating, and managing infectious wounds, which may arise from injuries, surgeries, or chronic health conditions. These wounds are characterized by the presence of harmful microorganisms such as bacteria or fungi and require specialized care to prevent complications. The product range includes antimicrobial dressings, topical antibiotics, wound cleansers, and advanced care solutions. Technological advancements continue to enhance the efficacy of wound care products by improving antimicrobial performance and tissue regeneration. The increasing prevalence of chronic conditions like diabetes and obesity has also heightened the demand for effective wound care solutions. As healthcare systems globally emphasize early intervention and infection control, the infectious wound care management sector is set to witness steady and sustained growth.

Key Market Drivers

Rising Incidence of Chronic Diseases

The surge in chronic diseases is a major catalyst for the global Infectious Wound Care Management Market. According to the World Obesity Atlas 2024, the number of adults living with obesity is projected to rise from 0.81 billion in 2020 to 1.53 billion by 2035. Chronic conditions such as diabetes, vascular disorders, and autoimmune diseases frequently lead to non-healing wounds, pressure sores, and ulcers, all of which are highly susceptible to infection. These patients often require specialized wound care solutions due to compromised immunity and delayed healing. As the global population continues to age and the burden of non-communicable diseases escalates, healthcare providers are increasingly turning to advanced wound care technologies. The focus on infection prevention, patient recovery, and quality of life has intensified demand for effective infectious wound care management products, driving market expansion and encouraging innovation across product categories.

Key Market Challenges

Antimicrobial Resistance

Antimicrobial resistance (AMR) presents a substantial challenge to the Global Infectious Wound Care Management Market. AMR occurs when pathogens become resistant to antimicrobial agents, reducing the efficacy of traditional treatments such as antibiotics and antifungal medications. This phenomenon complicates the management of infected wounds, often leading to prolonged healing times, higher healthcare expenditures, and increased risk of severe complications. In the context of wound care, AMR diminishes the effectiveness of commonly used therapies, necessitating the development of alternative strategies. These may include novel antimicrobial compounds, combination therapies, or non-antibiotic interventions. Ensuring appropriate antibiotic use and implementing rigorous infection control protocols are critical in mitigating AMR. As the global health community continues to address this issue, innovation in resistant-pathogen management and infection prevention becomes increasingly vital to maintaining the effectiveness of wound care solutions.

Key Market Trends

Regenerative Medicine

Regenerative medicine is emerging as a transformative trend in the Infectious Wound Care Management Market. This field leverages the body's natural healing mechanisms through the application of technologies such as stem cell therapy, growth factors, and tissue engineering to accelerate wound healing and tissue repair. These approaches are particularly effective for treating chronic or complex infectious wounds that are unresponsive to conventional treatments. Stem cells promote regeneration by differentiating into the necessary cell types, while growth factors aid in tissue proliferation and remodeling. Regenerative solutions not only reduce healing time but also help prevent infections and improve long-term outcomes. Although still under active research, regenerative medicine is poised to revolutionize wound care, offering innovative alternatives that enhance patient recovery, reduce healthcare costs, and address complications arising from non-healing wounds.

Key Market Players

• Molnlycke Health Care AB
• Hartmann Group
• Smith & Nephew PLC
• 3M Company
• Medtronic Plc
• B Braun Melsungen AG
• Johnson & Johnson
• Molnlycke Healthcare AB
• Conva Tec Inc.

Report Scope:

In this report, the Global Infectious Wound Care Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Infectious Wound Care Management Market, By Product Type:

• Therapeutics
• Device

Infectious Wound Care Management Market, By Wound Type:

• Diabetes Mellitus
• Hypoxia/Poor Tissue Perfusion
• Other

Infectious Wound Care Management Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Infectious Wound Care Management Market.

Available Customizations:

Global Infectious Wound Care Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Types
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Infectious Wound Care Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Therapeutics, Device)
  • 5.2.2. By Wound Type (Diabetes Mellitus, Hypoxia/Poor Tissue Perfusion, Other)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Product Type
  • 5.3.2. By Wound Type
  • 5.3.3. By Region

6. North America Infectious Wound Care Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Wound Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Infectious Wound Care Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Wound Type
  • 6.3.2. Canada Infectious Wound Care Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Wound Type
  • 6.3.3. Mexico Infectious Wound Care Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Wound Type

7. Europe Infectious Wound Care Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Wound Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Infectious Wound Care Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Wound Type
  • 7.3.2. France Infectious Wound Care Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Wound Type
  • 7.3.3. United Kingdom Infectious Wound Care Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Wound Type
  • 7.3.4. Italy Infectious Wound Care Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Wound Type
  • 7.3.5. Spain Infectious Wound Care Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Wound Type

8. Asia-Pacific Infectious Wound Care Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Wound Type
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Infectious Wound Care Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Wound Type
  • 8.3.2. Japan Infectious Wound Care Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Wound Type
  • 8.3.3. India Infectious Wound Care Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Wound Type
  • 8.3.4. South Korea Infectious Wound Care Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Wound Type
  • 8.3.5. Australia Infectious Wound Care Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Wound Type

9. South America Infectious Wound Care Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Wound Type
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Infectious Wound Care Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Wound Type
  • 9.3.2. Argentina Infectious Wound Care Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Wound Type
  • 9.3.3. Colombia Infectious Wound Care Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Wound Type

10. Middle East and Africa Infectious Wound Care Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Wound Type
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. UAE Infectious Wound Care Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Wound Type
  • 10.3.2. Saudi Arabia Infectious Wound Care Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Wound Type
  • 10.3.3. South Africa Infectious Wound Care Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Wound Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Porter's analysis

14. PESTEL analysis

15. Competitive Landscape

• 15.1. Molnlycke Health Care AB
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
• 15.2. Hartmann Group
• 15.3. Smith & Nephew PLC
• 15.4. 3M Company.
• 15.5. Smith & Nephew PLC
• 15.6. Medtronic Plc
• 15.7. B Braun Melsungen AG
• 15.8. Johnson & Johnson
• 15.9. Molnlycke Healthcare AB
• 15.10. Conva Tec Inc.

16. Strategic Recommendations

17. About Us & Disclaimer